1Année·
5
22 Commentaires

image de profil
Both ETFs are non-accumulating in my opinion.✌️
8
image de profil
@tommycash I could not select the accumulating one. Sorry 😅
image de profil
seems to be well thought out, I like the selection very much, only $XYL says me nothing... (gladly a contribution to it!) As tommycash has already written: both ETFs distribute. :) But seems to be the way it should be according to the strategy. 👍
image de profil
@Gerit
Xylem manufactures water treatment plants, analytical equipment, pumping systems, water filters, dysentery systems, heat exchangers, and all the necessary systems for wastewater treatment plants, waterworks, and water pipelines, as well as the associated pumping systems. Is market leader
3
image de profil
@AE23 Thanks for the explanation! :) How did you come up with this, perhaps somewhat unusual, pick?
image de profil
@Gerit i worked for years in water supply and disposal 😁
1
image de profil
@AE23

I've almost thought haha, would have surprised me if not ^ ^ Could with us like to share your investment case, simply as above in their own words, something more detailed, would offer absolute added value and the people here certainly like 👍
image de profil
@Gerit do you mean as a separate post, why xylem of all things?
1
image de profil
@AE23

because by now everyone should have a certain opinion about most of the big US companies. you read the same names far too often. i'm on something like GQ to read through something else, something like Xylem, an opinion that is not just written by someone, but by someone who has had a foot in the industry and just shows something fresh. i can already tell you that it will 99% not be an investment for me, but i'll gladly take the knowledge with me.
2
image de profil
@Gerit then please leave my new post and share your thoughts 😁
image de profil
Now a stupid question. You have 42 positions in your portfolio. You are talking about 6 stocks and 2 ETFs. Do you reallocate? Do you sell everything else? Or do you increase the mentioned and only these positions money flows in? What is your strategy and goal?
image de profil
@Joris I have sold a lot and restructured. I leave the rest in the portfolio to collect the dividends and now have standing orders on the positions mentioned.
image de profil
Linde is too expensive in my opinion P&G is a very good company I also have a savings plan Abbvie I also have a savings plan WM I once had a savings plan but they are currently overvalued to me
image de profil
@Miguel1602 World Cup overrated? Okay. According to what criteria?
image de profil
@AE23 P/E ratio of 28 KUV 3.5 KBV 10 For a waste management ?😅 Ehm yes
image de profil
@Miguel1602 despite the possible share price development and solid figures?
image de profil
Well the figures are now not outstanding even for this valuation. many have just invested in the company in corona times because the company would not generate bad figures through corona. how much growth should still arise in a waste management ?
image de profil
ABBVIE is deep red today at -7.6%. Who knows why?
image de profil
@Wundersamen Patent from blockbuster humira has expired. Quarterly figures were published today. Profit decline was as expected by analysts, but investors are used to the company exceeding expectations. So sharp price drop, in my opinion, not justified. 🤷🏼‍♂️
image de profil
Would you buy limited now or hold?
image de profil
@Wundersamen I am torn. I actually wanted to end my standing order and hold the position. but in view of the price slide, I'll let the standing order continue for another quarter. it's still a mega biotech stock. and one of the future trends. but I probably won't make any more large purchases in the pharma sector. this patent debacle is too nerve-wracking for me. instead, I'll continue to save my sector ETF, in which everyone is simply in it and I cover the whole sector. then I'll have peace 😅
image de profil
@Wundersamen AbbVie won the lottery with their humira patent. No drug has helped better. Is the same effect as the Corona vaccine at Pfizer 🤷🏼‍♂️
Participez à la conversation